Allstate (NYSE:ALL – Get Free Report) issued its quarterly earnings data on Wednesday. The insurance provider reported $5.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.11 by $1.02, Briefing.com reports. The firm had revenue of $15.26 billion during the quarter, compared to the consensus estimate of $12.76 billion. Allstate had a net margin of 2.31% and a return on equity of 14.44%. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period last year, the business posted ($1.30) earnings per share.
Allstate Trading Down 0.6 %
Shares of NYSE ALL traded down $1.00 during trading hours on Friday, hitting $168.18. The company’s stock had a trading volume of 1,668,295 shares, compared to its average volume of 1,508,644. Allstate has a 12 month low of $100.57 and a 12 month high of $177.37. The stock has a market cap of $44.39 billion, a price-to-earnings ratio of 37.13, a P/E/G ratio of 0.40 and a beta of 0.51. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.37 and a current ratio of 0.36. The business has a 50-day simple moving average of $165.88 and a 200-day simple moving average of $150.65.
Allstate Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 2.19%. This is an increase from Allstate’s previous quarterly dividend of $0.89. The ex-dividend date of this dividend was Friday, March 1st. Allstate’s dividend payout ratio is 81.24%.
Insiders Place Their Bets
Analyst Upgrades and Downgrades
Several analysts recently weighed in on ALL shares. TheStreet raised shares of Allstate from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. HSBC raised Allstate from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $158.00 to $190.00 in a report on Thursday, March 28th. Wells Fargo & Company upped their price objective on shares of Allstate from $145.00 to $146.00 and gave the stock an “underweight” rating in a research report on Thursday, April 11th. Evercore ISI raised their target price on Allstate from $166.00 to $173.00 and gave the company an “in-line” rating in a research report on Thursday, April 11th. Finally, Morgan Stanley boosted their price objective on Allstate from $187.00 to $190.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $174.18.
Get Our Latest Stock Analysis on ALL
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- MarketBeat Week in Review – 4/29 – 5/3
- Stock Analyst Ratings and Canadian Analyst Ratings
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Health Care Stocks Explained: Why You Might Want to Invest
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.